Molex LLC:企業のM&A・事業提携・投資動向

◆英語タイトル:Molex LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2329
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Molex LLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Molex LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Molex LLC since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Molex LLC’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Molex LLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Molex LLC’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Molex LLC and its subsidiaries since 2007.
- Information about key financial and legal advisors for Molex LLC’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Molex LLC’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 38
Corporate Venturing – Overview 38
Corporate Venturing – Deal reports 39
PARTNERSHIP 43
Partnership – Overview 43
Partnership – Deal reports 44
Divestments – Deal reports 50
PRIVATE EQUITY & OWNERSHIP 52
Private Equity and Ownership – Deal reports 52
APPENDIX 56
Contact Us 56
About MarketLine Financial Deals Database 56
Deal Definition and Methodology 58
About MarketLine 65

List of Tables
Table 1: Molex LLC M&A volume and value trend (2014-YTD2018)
Table 2: Molex LLC M&A activity by geography (2014-YTD2018)
Table 3: Molex LLC corporate venturing volume and value trend (2014-YTD2018)
Table 4: Molex LLC corporate venturing by geography (2014-YTD2018)
Table 5: Molex LLC partnership volume and value trend (2014-YTD2018)
Table 6: Molex LLC partnership trend by key deal type (2014-YTD2018)

List of Figures
Figure 1: Molex LLC M&A volume and value trend (2014-YTD2018)
Figure 2: Molex LLC M&A activity by geography (2014-YTD2018)
Figure 3: Molex LLC corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Molex LLC corporate venturing by geography (2014-YTD2018)
Figure 5: Molex LLC partnership volume and value trend (2014-YTD2018)
Figure 6: Molex LLC partnership trend by key deal type (2014-YTD2018)

★海外企業調査レポート[Molex LLC:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • e-Therapeutics Plc (ETX):企業の財務・戦略的SWOT分析
    e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Prismic Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prismic Pharmaceuticals Inc (Prismic Pharmaceuticals) is a specialty pharmaceutical company that offers development of prescription drugs. The company offers research and development programs for prescription product candidates and provides unique safety profiles. It develops drugs for infla …
  • Tokyo Gas Co., Ltd.:企業の戦略・SWOT・財務分析
    Tokyo Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokyo Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Albireo Pharma Inc (ALBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Zara Investment (Holding) Co Ltd
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cincinnati Bell Inc.:企業の戦略・SWOT・財務情報
    Cincinnati Bell Inc. - Strategy, SWOT and Corporate Finance Report Summary Cincinnati Bell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • F. Hoffmann-La Roche Ltd:企業の戦略・SWOT・財務情報
    F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report Summary F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Neurocrine Biosciences Inc (NBIX)-製薬・医療分野:企業M&A・提携分析
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • OncoSec Medical Inc (ONCS):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Petronas Dagangan Berhad (PETDAG):企業の財務・戦略的SWOT分析
    Petronas Dagangan Berhad (PETDAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • HealthCare Global Enterprises Ltd (HCG):企業の財務・戦略的SWOT分析
    Summary HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that provides medical care and treatment services. The company provides services such as clinical laboratory services, diagnosis services, medical oncology services, radiat …
  • ManTech International Corporation:企業の戦略・SWOT・財務情報
    ManTech International Corporation - Strategy, SWOT and Corporate Finance Report Summary ManTech International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Diageo plc:企業の戦略・SWOT・財務情報
    Diageo plc - Strategy, SWOT and Corporate Finance Report Summary Diageo plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Clay Electric Cooperative Inc:企業の戦略的SWOT分析
    Clay Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • CPFL Energia SA (CPFE3):電力:M&Aディール及び事業提携情報
    Summary CPFL Energia S.A. (CPFL), formerly Companhia Paulista de Forca e Luz, is an electric utility, which carries out regulated and non-regulated electricity business. The company through its subsidiaries generates, transmits, distributes and commercializes electricity. It generates electricity us …
  • Hera SpA (HER):企業の財務・戦略的SWOT分析
    Hera SpA (HER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • VWR International LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary VWR International LLC (VWR), a subsidiary of Avantor Performance Materials Inc, is a provider of product and service solutions to laboratory and production companies. The company offers products such as adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshe …
  • Evraz Plc:企業のM&A・事業提携・投資動向
    Evraz Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evraz Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Etiqa Insurance Berhad:企業の戦略的SWOT分析
    Etiqa Insurance Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SOGLASIE Insurance Company Ltd.:企業の戦略・SWOT・財務情報
    SOGLASIE Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary SOGLASIE Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆